Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,338 |
Ending reported balance
After 2026-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 298,338 Row 2 · 2026-03-18 · Grant · Acquired 4,000 · Balance 302,338 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.41 | $200.17 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,374 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 18, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.12 | $189.44 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,337 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:15 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 4,000 | $5.17 | $20,680.00 |
DisclosureSEC source: 0001628280-25-013546 · wk-form4_1742332498.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,843 F1 · shares: Restricted stock award will vest 100% on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:15 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantCommon Stock | 1,000 | $5.17 | $5,170.00 |
DisclosureSEC source: 0001628280-25-013546 · wk-form4_1742332498.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,843 F1 · shares: Restricted stock award will vest 100% on March 17, 2026. Read SEC document |
| March 17, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.41 | $200.17 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,300 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 14, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.38 | $199.06 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,263 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 13, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.47 | $202.39 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,226 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 12, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.17 | $191.29 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,189 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 11, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $4.85 | $179.45 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,152 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 10, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 37 | $5.85 | $216.45 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,115 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 07, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 47 | $6.51 | $305.97 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,078 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 06, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 47 | $6.57 | $308.79 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 283,031 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 05, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 47 | $6.75 | $317.25 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,984 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 04, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 47 | $5.11 | $240.17 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,937 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 03, 2025 Filed Apr 4, 2025 17:36 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 47 | $5.54 | $260.38 |
DisclosureSEC source: 0001628280-25-016741 · wk-form4_1743788198.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 282,890 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 20, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 301 | $2.35 | $707.35 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,343 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 19, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 266 | $2.33 | $619.78 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 276,042 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 18, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 312 | $2.19 | $683.28 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,776 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 17, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 312 | $2.12 | $661.44 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,464 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 16, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 312 | $2.21 | $689.52 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 275,152 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 13, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 197 | $2.33 | $459.01 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,840 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 12, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 197 | $2.19 | $431.43 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,643 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 11, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 197 | $2.29 | $451.13 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,446 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 10, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 197 | $2.48 | $488.56 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,249 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 09, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 415 | $1.25 | $518.75 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,052 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 06, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 415 | $1.20 | $498.00 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,637 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 05, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 350 | $1.20 | $420.00 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 273,222 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 04, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 415 | $1.22 | $506.30 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,872 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 03, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 415 | $1.26 | $522.90 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,457 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 02, 2024 Filed Dec 31, 2024 00:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 415 | $1.33 | $551.95 |
DisclosureSEC source: 0001628280-24-052603 · wk-form4_1735605706.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 272,042 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 29, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 474 | $1.32 | $625.68 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 20 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,627 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 27, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 474 | $1.15 | $545.10 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 19 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 271,153 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 26, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 474 | $1.11 | $526.14 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 18 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,679 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 25, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 474 | $1.09 | $516.66 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 17 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,205 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 22, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 474 | $1.07 | $507.18 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 16 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,731 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 21, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 427 | $1.09 | $465.43 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 15 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,257 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 20, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 427 | $1.13 | $482.51 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,830 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 19, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.15 | $437.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,403 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 18, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.18 | $448.40 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,023 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 15, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.17 | $444.60 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,643 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 14, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.19 | $452.20 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 267,263 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 13, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.20 | $456.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,883 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 12, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.20 | $456.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,503 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 11, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.20 | $456.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 266,123 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 08, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.18 | $448.40 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,743 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 07, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.17 | $444.60 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 265,363 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 06, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.20 | $456.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,983 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 05, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.20 | $456.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,603 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 04, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 245 | $1.17 | $286.65 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,223 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 01, 2024 Filed Dec 5, 2024 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 380 | $1.15 | $437.00 |
DisclosureSEC source: 0001628280-24-050104 · wk-form4_1733436149.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 263,978 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.